272 related articles for article (PubMed ID: 29346435)
1. Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs.
Kosik I; Ince WL; Gentles LE; Oler AJ; Kosikova M; Angel M; Magadán JG; Xie H; Brooke CB; Yewdell JW
PLoS Pathog; 2018 Jan; 14(1):e1006796. PubMed ID: 29346435
[TBL] [Abstract][Full Text] [Related]
2. Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.
Magadán JG; Altman MO; Ince WL; Hickman HD; Stevens J; Chevalier A; Baker D; Wilson PC; Ahmed R; Bennink JR; Yewdell JW
PLoS Pathog; 2014 Jun; 10(6):e1004204. PubMed ID: 24945804
[TBL] [Abstract][Full Text] [Related]
3. Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.
Dinis JM; Florek KR; Fatola OO; Moncla LH; Mutschler JP; Charlier OK; Meece JK; Belongia EA; Friedrich TC
J Virol; 2016 Jan; 90(7):3355-65. PubMed ID: 26739054
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model.
Roubidoux EK; Carreño JM; McMahon M; Jiang K; van Bakel H; Wilson P; Krammer F
mBio; 2021 Feb; 12(1):. PubMed ID: 33593972
[TBL] [Abstract][Full Text] [Related]
5. Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses.
Job ER; Deng YM; Barfod KK; Tate MD; Caldwell N; Reddiex S; Maurer-Stroh S; Brooks AG; Reading PC
J Immunol; 2013 Mar; 190(5):2169-77. PubMed ID: 23365085
[TBL] [Abstract][Full Text] [Related]
6. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift.
Hensley SE; Das SR; Bailey AL; Schmidt LM; Hickman HD; Jayaraman A; Viswanathan K; Raman R; Sasisekharan R; Bennink JR; Yewdell JW
Science; 2009 Oct; 326(5953):734-6. PubMed ID: 19900932
[TBL] [Abstract][Full Text] [Related]
7. Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations
Davis AKF; McCormick K; Gumina ME; Petrie JG; Martin ET; Xue KS; Bloom JD; Monto AS; Bushman FD; Hensley SE
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045982
[TBL] [Abstract][Full Text] [Related]
8. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
[TBL] [Abstract][Full Text] [Related]
9. Adsorptive mutation and N-linked glycosylation modulate influenza virus antigenicity and fitness.
Sealy JE; Peacock TP; Sadeyen JR; Chang P; Everest HJ; Bhat S; Iqbal M
Emerg Microbes Infect; 2020 Dec; 9(1):2622-2631. PubMed ID: 33179567
[TBL] [Abstract][Full Text] [Related]
10.
An Y; Parsons LM; Jankowska E; Melnyk D; Joshi M; Cipollo JF
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355697
[TBL] [Abstract][Full Text] [Related]
11. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
[TBL] [Abstract][Full Text] [Related]
12. Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution.
Kim JI; Lee I; Park S; Hwang MW; Bae JY; Lee S; Heo J; Park MS; García-Sastre A; Park MS
J Virol; 2013 Jul; 87(13):7539-49. PubMed ID: 23637398
[TBL] [Abstract][Full Text] [Related]
13. Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.
Koel BF; Mögling R; Chutinimitkul S; Fraaij PL; Burke DF; van der Vliet S; de Wit E; Bestebroer TM; Rimmelzwaan GF; Osterhaus AD; Smith DJ; Fouchier RA; de Graaf M
J Virol; 2015 Apr; 89(7):3763-75. PubMed ID: 25609810
[TBL] [Abstract][Full Text] [Related]
14. L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.
Wang Y; Lv Y; Niu X; Dong J; Feng P; Li Q; Xu W; Li J; Li C; Li J; Luo J; Li Z; Liu Y; Tan YJ; Pan W; Chen L
J Virol; 2020 Sep; 94(20):. PubMed ID: 32796071
[TBL] [Abstract][Full Text] [Related]
15. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain.
Das SR; Puigbò P; Hensley SE; Hurt DE; Bennink JR; Yewdell JW
PLoS Pathog; 2010 Nov; 6(11):e1001211. PubMed ID: 21124818
[TBL] [Abstract][Full Text] [Related]
17. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
Front Immunol; 2019; 10():756. PubMed ID: 31105689
[TBL] [Abstract][Full Text] [Related]
18. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
19. Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry.
Cruz E; Cain J; Crossett B; Kayser V
Hum Vaccin Immunother; 2018 Mar; 14(3):508-517. PubMed ID: 29048990
[TBL] [Abstract][Full Text] [Related]
20. Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit.
Altman MO; Angel M; Košík I; Trovão NS; Zost SJ; Gibbs JS; Casalino L; Amaro RE; Hensley SE; Nelson MI; Yewdell JW
mBio; 2019 Apr; 10(2):. PubMed ID: 30940704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
